Sophie Lotersztajn

4PUBLICATIONS
13CO-AUTHORS
Haematological tumoursCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 24, 2025
Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation.

Rola Al Sayegh, Jinghong Wan, Charles Caër

|May 22, 2023
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma.

Hélène Gilgenkrantz, Valérie Paradis, Sophie Lotersztajn

|Apr 03, 2023
MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming.

Morgane Mabire, Pushpa Hegde, Adel Hammoutene

|Apr 17, 2020
LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling.

JingHong Wan, Emmanuel Weiss, Sanae Ben Mkaddem

Pageof 1